6264
S. G. Ruf et al. / Tetrahedron 56 (2000) 6259±6267
surprising and diverse reactivity. The formation of 7, in
particular, poses a number of as yet unresolved mechanistic
questions. Further investigations with this objective are at
present in progress.
From 1000 mg oxirane (1, 3.35 mmol) and 3.35 mmol phos-
phaalkyne 3b, yield: 983 mg (70%), mp 938C; 31P NMR
(C6D6): d267.2 (s); H NMR (C6D6): d0.55 (pt, 3H,
1
4
3JH,H7.4 Hz, ±C(CH3)(CH3)CHHCH3), 0.89 (d, 3H, JH,P
1.0 Hz, ±C(CH3)(CH3)CHHCH3), 1.11 (s, 3H, ±C(CH3)(CH3)
CHHCH3), 1.10±1.19 (m, 1H, ±C(CH3)(CH3)CHHCH3),
1.37±1.46 (m, 1H, ±C(CH3)(CH3)CHHCH3), 6.69±8.83 (m,
Experimental
14H, aryl-H); 13C NMR (C6D6): d8.7 (d, JC,P1.2 Hz,
4
3
±C(CH3)(CH3)CHHCH3), 30.3 (d, JC,P13.7 Hz, ±C(CH3)
General
3
(CH3)CHHCH3), 30.7 (d, JC,P14.5 Hz, ±C(CH3)(CH3)
3
CHHCH3), 35.9 (d, JC,P9.6 Hz, ±C(CH3)(CH3)CHHCH3),
All experiments were carried out under argon
(purity.99.998%) in previously evacuated and baked
Schlenk vessels. When the reaction mixture had to be heated
to temperatures above the boiling point of the solvent,
special pressure Schlenk tubes (glass tubes, 3£5 cm2, wall
thickness 2 mm) with screw-threaded Te¯on stoppers and
Te¯on stopcocks were used. The solvents were dried by
standard procedures, distilled and stored under argon until
used. Melting points were determined on a Mettler FP61
apparatus (heating rate 28C min21) and are uncorrected.
NMR spectra were recorded on Bruker WP200 and
2
43.1 (d, JC,P10.8 Hz, ±C(CH3)(CH3)CHHCH3), 94.7 (d,
1JC,P38.2 Hz, C-1), 98.2 (d, JC,P8.8 Hz, C-9), 122.7 (d,
2
JC,P1.2 Hz), 127.6 (s), 127.9 (s), 128.0 (s), 128.1 (s), 128.2
(s), 128.5 (s), 128.7 (s), 129.0 (s), 132.2 (s), aryl-C, 126.8
(s), 148.4 (d, JC,P2.8 Hz), C-2 and C-7, 138.7 (d,
3JC,P4.4 Hz, C-10), 140.2 (d, JC,P10.8 Hz, C-100), 189.2
2
(d, 3JC,P10.0 Hz, C-8,), 210.5 (d, 1JC,P46.8 Hz, C-10); IR
(CH2Cl2): n2966 (m, CH), 1698 (vs, CO), 1594 (s), 1201
(m), 1026 (m), 836 (w); MS (EI, 70 eV): m/z (%)412
(70.3) [M]1, 397 (5.7) [M2Me]1, 383 (13.0) [M2Et]1,
342 (31.0) [M2C5H10]1, 105 (100.0) [PhCO]1, 77 (41.0)
[Ph]1, 71 (4.3) [C5H11]1; C27H25O2P (412.37 g/mol): calcd
C 78.62, H 6.11; found C 78.22, H 6.30.
1
AMX400 instruments. Chemical shifts for H and 13C are
reported in ppm relative to the solvent as internal standard;
the chemical shifts for 31P are expressed relative to external
85% orthophosphoric acid. Elemental analyses were
performed on a Perkin±Elmer Analyser 2400. IR spectra
were measured on a Perkin±Elmer 16 PC FT-IR spectro-
photometer and mass spectra were recorded on a Finnigan
MAT90 spectrometer. Compounds 131 and 332 were
prepared according to published methods.
10-(1-Methylcyclohexyl)-1,9-diphenyl-12-oxa-11-phospha-
(4c).
tricyclo[7.2.1.02,7]dodeca-2,4,6,10-tetraen-8-one
From 1000 mg oxirane (1, 3.35 mmol) and 3.35 mmol phos-
phaalkyne 3c, yield: 415 mg (28%), mp 1028C; 31P NMR
(CDCl3): d268.5 (s); 1H NMR (CDCl3): d0.74 (s, 3H, ±
CH3), 1.05±1.60 (m, 10H, alkyl-H), 6.81±8.21 (m, 14H,
4
aryl-H); 13C NMR (CDCl3): d22.1 (d, JC,P2.9 Hz),
10-Alkyl-1,9-diphenyl-12-oxa-11-phosphatricyclo[7.2.1.02,7]
dodeca-2,4,6,10-tetraen-8-ones (4a±d). Solutions of equi-
molar amounts of oxirane 1 and the phosphaalkynes 3a±d
in 15 ml CH2Cl2 were heated for 18 h at 1508C under 5 bar
Ar overpressure. After evaporation of the solvent the residue
was dissolved in 5 ml of CH2Cl2 and subjected to ¯ash
chromatography on silica gel 60 with an n-pentane/ether
mixture (80:1) to furnish the products as pale yellow solids.
4
3
22.3 (s, JC,P2.4 Hz), 25.5 (d, JC,P9.2 Hz), 25.6 (s),
3
3
39.4 (d, JC,P13.8 Hz), 41.2 (d, JC,P15.7 Hz), 43.4 (d,
1
2JC,P9.5 Hz), alkyl-C, 94.5 (d, JC,P38.1 Hz, C-1), 97.8
(d, 2JC,P9.5 Hz, C-9), 122.8 (s), 127.6 (s), 127.8 (s), 128.0
(s), 128.1 (s), 128.2 (s), 128.6 (s), 128.7 (s), 129.1 (s), 132.4
(s), aryl-C, 126.7 (s), 148.3 (s), C-2 and C-7, 139.0 (d,
2
3JC,P4.3 Hz, C-10), 140.0 (d, JC,P10.4 Hz, C-100), 189.7
3
1
(d, JC,P9.5 Hz, C-8), 213.9 (d, JC,P46.7 Hz, C-10); IR
(CCl4): n3062 (w, CH), 2930 (vs, CH), 2856 (m, CH),
1702 (vs, CO), 1677 (m), 1596 (w), 1494 (w), 1447 (s),
1282 (m), 1261 (m), 1201 (m), 1029 (m), 697 (vs); MS
(EI, 35 eV): m/z (%)438 (47.2) [M]1, 342 (40.0)
[M2C7H12]1, 105 (88.9) [PhCO]1; C29H27O2P (438.50 g/
mol).
10-tert-Butyl-1,9-diphenyl-12-oxa-11-phosphatricy-
clo[7.2.1.02,7] dodeca-2,4,6,10-tetraen-8-one (4a). From
2000 mg oxirane (1, 6.70 mmol) and 670 mg phosphaalk-
yne (3a, 6.70 mmol), yield: 2000 mg (75%), mp 968C; 31P
NMR (CDCl3): d261.4 (s); 1H NMR (CDCl3): d1.04 (d,
4
9H, JH,P1.2 Hz, C(CH3)3), 6.81±8.09 (m, 14H, aryl-H);
3
13C NMR (CDCl3): d32.9 (d, JC,P13.0 Hz, C(CH3)3),
2
1
10-(Adamant-1-yl)-1,9-diphenyl-12-oxa-11-phospha-
(4d).
37.2 (d, JC,P13.0 Hz, C(CH3)3), 94.4 (d, JC,P37.8 Hz,
C-1), 98.0 (d, 2JC,P8.9 Hz, C-9), 122.8 (s), 127.7 (s), 127.9
(s), 128.00 (s), 128.03 (s), 128.1 (s), 128.3 (s), 128.6 (s),
129.0 (s), 132.4 (s), aryl-C, 126.7 (s), 148.3 (s), C-2 and C-7,
tricyclo[7.2.1.02,7]dodeca-2,4,6,10-tetraen-8-one
From 1000 mg oxirane (1, 3.35 mmol) and 3.35 mmol phos-
phaalkyne 3d, yield: 846 mg (52%), mp 1058C, 31P NMR
1
3
2
138.5 (d, JC,P4.0 Hz, C-10), 139.9 (d, JC,P10.4 Hz, C-
100), 189.6 (d, 3JC,P10.4 Hz, C-8), 212.5 (d, 1JC,P45.0 Hz,
C-10); IR (CCl4): n2962 (s, CH), 1698 (vs, CvO), 1594
(s), 1492 (m), 1448 (w), 1446 (s), 1364 (m), 1280 (s), 1200
(s), 1184 (m), 1060 (m), 1027 (s), 836 (s); MS (EI, 70 eV):
m/z (%)398 (5.6) [M]1, 342 (2.8) [M2C4H8]1, 105 (37.6)
[Ph-CO]1, 77 (16.6) [C6H5]1, 57 (47.0) [C4H9]1; C26H23O2P
(398.43 g/mol): calcd C 78.39, H 5.78; found C 77.50, H
5.75.
(C6D6): d267.8 (s); H NMR (C6D6): d1.30±2.06 (m,
15H, alkyl-H), 6.75±8.43 (m, 14H, aryl-H); 13C NMR
4
(CDCl3): d28.6 (d, JC,P1.6 Hz), 36.1 (s), 42.9 (d,
3
2JC,P10.4 Hz), 44.4 (s, JC,P13.3 Hz), alkyl-C, 94.6 (d,
2
1JC,P38.2 Hz, C-1), 97.6 (d, JC,P8.4 Hz, C-9), 122.8
(s), 127.6 (s), 127.9 (s), 128.0 (d, JC,P4.0 Hz), 128.0 (d,
JC,P5.2 Hz), 128.3 (s), 128.6 (s), 128.6 (s), 129.0 (s), 132.4
(s), aryl-C, 126.7 (s), 148.4 (d, JC,P1.6 Hz), C-2 and C-7,
3
2
138.9 (d, JC,P4.4 Hz, C-10), 140.0 (d, JC,P10.4 Hz,
3
C-100), 189.7 (d, JC,P10.0 Hz, C-8), 213.8 (d,
1JC,P45.8 Hz, C-10); IR (CCl4): n3066 (w, CH), 2909
10-(1,1-Dimethylpropyl)-1,9-diphenyl-12-oxa-11-phospha-
tricyclo[7.2.1.02,7]dodeca-2,4,6,10-tetraen-8-one
(vs, CH), 2852 (m, CH), 1703 (m, CO), 1596 (w), 1493
(4b).